Market Herald logo

Subscribe

Be the first with the news that moves the market
  • MCI Onehealth (DRDR) and Euclid Telehealth collaborate to improve patient vision outcomes through data-driven screening
  • The goal is to provide improved health outcomes, a better quality of life and significant cost avoidance for the healthcare system
  • MCI is using its data insights infrastructure to help family physicians identify patients within their practices that might be at risk for eye disease
  • Patients are then contacted by MCI to confirm their interest in attending a diagnostic session provided by Euclid at the MCI clinic
  • There are hundreds of people who have gone through the program to date
  • MCI Onehealth Technologies (DRDR) is down 1.48 per cent, trading at C$1.33 at 11:55 am ET

MCI Onehealth (DRDR) and Euclid Telehealth are collaborating to increase access to care that can potentially prevent vision loss among Ontario patients.

The goal is to provide improved health outcomes, a better quality of life and significant cost avoidance for the healthcare system.

“Through data-driven screening, MCI is helping physicians connect with patients that have potentially heightened risk of certain diseases, so our physicians can get them onto the right care pathways,” said Jennifer Foster, Chief Operating Officer of MCI.

MCI is using its data insights infrastructure to help family physicians identify patients within their practices that might be at risk for eye disease.

Patients are then contacted by MCI to confirm their interest in attending a diagnostic session provided by Euclid at the MCI clinic.

This specific care pathway is in place to add convenience, including personalized care that encourages patient uptake of the service, with MCI and Euclid seeing up to 20 patients at each screening day.

Hundreds of people have gone through the program to date. Euclid-day clinics MCI sites happen based on patient need, currently occurring about once per week at multiple sites.

“Early detection, diagnosis and timely management of many eye conditions minimize vision loss, and in some cases, can even restore vision,” said Dr. Delan Jinapriya, Ophthalmologist, Surgeon & Founder Euclid Telehealth.

In addition, MCI and Euclid promote awareness of the risk factors and diagnostic options to potential patients outside the MCI network and among MCI staff and physicians, such that even first-time patients with appropriate risk factors can be flagged.

It is known that 1 in 5 Canadians will develop significant, preventable vision loss in their lifetime.

Also, more than 8 million Canadians are living with eye disease from one of the four defined main conditions, of which 1.2 million have vision loss from their disease.

MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies.

While Euclid Telehealth is an eye care telehealth company opting to provide access to expert eye health care delivered by leading medical professionals. 

MCI Onehealth Technologies (DRDR) is down 1.48 per cent, trading at C$1.33 at 11:55 am ET.


More From The Market Herald
VitalHub

" VitalHub (TSX:VHI) announces multi year contract with NHS Mid and South Essex ICB

VitalHub (VHI) announced a multi-year licensing contract with NHS Mid and South Essex Integrated Care Board (Essex).
Resverlogix Corp. - SVP of Clinical Development, Dr. Michael Sweeney.

" Resverlogix (TSX:RVX) focuses drug development on COVID-19

Clinical development of Resverlogix’s (RVX) candidate apabetalone will remain focused on preventing and treating post-COVID-19 conditions.

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.